Effect of Synbiotics on Neonatal hyperbilirubinemia
Phase 3
Recruiting
- Conditions
- neonatal hyperbilirubinemia and symbiotic effect on its treatment.
- Registration Number
- IRCT20180228038895N1
- Lead Sponsor
- Rasht University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 194
Inclusion Criteria
Age between 3-14 days
Total bilirubin between 15-22 mg/dl and direct bill <1.5
Exclusive breast feeding
Without underlying disease
Weight>2500gr
Exclusion Criteria
Sepsis
Cephalhematoma
ABO incompatibility
G6PD deficiency
Underlying disease
Parental dissatisfaction
Polycythemia
RH incompatibility
Formula feeding
Treated by Phenobarbital .billinaster.etc...
Transfer to NICU
Down Syndrome
Family history of Immune deficiency
Blood exchange
Treated by Antibiotics
Serum therapy
Hemolysis
Diabetes in Mother
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Bilirubin level. Timepoint: Measurement of Bilirubin in admission day and daily until discharge(8 AM). Method of measurement: Measurement of serum bilirubin in laboratory by Pars Azmoon kits.
- Secondary Outcome Measures
Name Time Method Daily defecation numbers. Timepoint: Daily at 8 AM until discharge. Method of measurement: Question from parents.